LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q1 2024

Top Holdings315 positions

Checking export access…
Activity:
??MICROSTRATEGY INCDelisted
Bond
153M$656.2M5.2%———
Increased
99
??SEA LTDDelisted
293M$294.2M2.3%———
Increased
56
??MONGODB INCDelisted
Bond
164.5M$288.2M2.3%———
Increased
55
??LI AUTO INCDelisted
Bond
218.8M$274.9M2.2%——
8 qtrssince 2022-Q2
Increased
57
??ROYAL CARIBBEAN GROUPDelisted
Bond
85.9M$244.2M1.9%———
Decreased
0
267.1M$231.6M1.8%———
Increased
68
??CONFLUENT INCDelisted
Bond
263.2M$226.3M1.8%———
Increased
60
186.2M$217.9M1.7%———
Increased
54
70.4M$215.2M1.7%———
Increased
49
135.1M$214.4M1.7%———
Increased
78
??CYBERARK SOFTWARE LTDDelisted
Bond
113.2M$192.8M1.5%———
Increased
78
202.8M$190.3M1.5%———
Increased
74
??SNAP INC
Bond
246.7M$188M1.5%———
Increased
62
??LIVONGO HEALTH INCDelisted
Bond
186.6M$176.7M1.4%———
Decreased
0
173.9M$170M1.3%———
Increased
75
??COINBASE GLOBAL INCDelisted
Bond
145.3M$159.7M1.3%———
Increased
57
??SPOTIFY USA INCDelisted
Bond
159.2M$146.5M1.2%———
Increased
77
187.5M$145.3M1.2%——
5 qtrssince 2023-Q1
Increased
53
??ASCENDIS PHARMA ADelisted
Bond
124M$143.3M1.1%———
Increased
77
??DAYFORCE INCDelisted
Bond
155.4M$142.8M1.1%———
Increased
53
$12.6B
AUM
315
Positions
Q1 2024
Filing
HI score · 2.0/5
Quarterly 13F Value Change
+0%Q3'22$10.9B-13%Q4'22$9.5B-0%Q1'23$9.5B+0%Q2'23$9.5B+2%Q3'23$9.7B+8%Q4'23$10.5B
Activity profile
$ moved · Q1'24
New16%Increased56%Decreased10%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 years
<1Q7%1-4Q19%1-2Y27%2Y+47%

LINDEN ADVISORS LP manages $12.6B across 315 positions as of Q1 2024. Top holdings: MICROSTRATEGY INC (5.2%), SEA LTD (2.3%), MONGODB INC (2.3%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.

Q1 2024 Summary

Active quarter - 32 new positions, 49 exits, 98 increased. No standout high-conviction moves this quarter. Portfolio: $12.6B across 315 positions.

Top holdings by portfolio weight

Total AUM$13B
MICROSTRATEG5.20%
SEA LTD2.33%
MONGODB INC2.28%
LI AUTO INC2.18%
ROYAL CARIBB1.93%
DRAFTKINGS I1.83%
CONFLUENT IN1.79%
SAREPTA THER1.73%
UNITED STATE1.70%
CYTOKINETICS1.70%
Other1.53%

Portfolio allocation by GICS sector

Sectors6
Unknown36.63%
Financial Services27.47%
Technology21.15%
Basic Materials14.20%
Industrials0.49%
Utilities0.06%

Behavioral investing profile

Checking access…
Diversified Scout
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L58
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used